These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17867252)

  • 1. Antimicrobial resistance in Neisseria gonorrhoeae and limited treatment options.
    Zafar A; Jabeen K
    J Pak Med Assoc; 2007 Jul; 57(7):333-4. PubMed ID: 17867252
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan.
    Ohnishi M; Saika T; Hoshina S; Iwasaku K; Nakayama S; Watanabe H; Kitawaki J
    Emerg Infect Dis; 2011 Jan; 17(1):148-9. PubMed ID: 21192886
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
    Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
    Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic susceptibility of Neisseria gonorrhoeae in Guadalajara area].
    Arias M; Tena D; Bisquert J
    Rev Esp Quimioter; 2011 Mar; 24(1):48-9. PubMed ID: 21412670
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated from Guangzhou, China, 2000 to 2005 and 2008 to 2013.
    Cao WL; Liang JY; Li XD; Bi C; Yang RD; Liang YH; Li P; Zhong DQ; Ye XD; Zhang XB
    Sex Transm Dis; 2015 Jan; 42(1):27-9. PubMed ID: 25504297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gonococci change more quickly than prescribing practices; resistance to frequently prescribed antibiotics].
    Koedijk FD; van den Broek I; Stirbu-Wagner I; van Bergen JE
    Ned Tijdschr Geneeskd; 2013; 157(24):A5642. PubMed ID: 23759175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin.
    Whiley DM; Jennison A; Pearson J; Lahra MM
    Lancet Infect Dis; 2018 Jul; 18(7):717-718. PubMed ID: 29976521
    [No Abstract]   [Full Text] [Related]  

  • 8. An era of untreatable gonorrhoea?
    Sutton B; Ivan M
    Med J Aust; 2018 Aug; 209(4):188. PubMed ID: 30107775
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antimicrobial resistance in Neisseria gonorrheae in North-East Romania].
    Bădescu AC; Petrescu Z; Enache A; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(2):512-5. PubMed ID: 17983194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice alert: CDC no longer recommends quinolones for treatment of gonorrhea.
    Campos-Outcalt D
    J Fam Pract; 2007 Jul; 56(7):554-8. PubMed ID: 17605948
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam.
    Adamson PC; Hieu VN; Nhung PH; Whiley DM; Chau TM
    Lancet Infect Dis; 2024 Jun; 24(6):e351-e352. PubMed ID: 38723652
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of antimicrobial resistance in Neisseria gonorrhoeae in an HIV/AIDS clinic.
    Chan DJ; Tapsall J
    Int J STD AIDS; 2006 Jun; 17(6):410-2. PubMed ID: 16734965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988 and 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 May; 39(17):284-7, 293. PubMed ID: 2139166
    [No Abstract]   [Full Text] [Related]  

  • 14. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC update on gonorrhea: expand treatment to limit resistance.
    Campos-Outcalt D
    J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
    [No Abstract]   [Full Text] [Related]  

  • 16. First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.
    Carnicer-Pont D; Smithson A; Fina-Homar E; Bastida MT;
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):218-9. PubMed ID: 22244992
    [No Abstract]   [Full Text] [Related]  

  • 17. Global resistance of Neisseria gonorrhoeae: when theory becomes reality.
    Lewis DA
    Curr Opin Infect Dis; 2014 Feb; 27(1):62-7. PubMed ID: 24275696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines.
    Farhi D; Hotz C; Poupet H; Gerhardt P; Morand P; Poyart C; Sednaoui P; Avril MF; Dupin N
    Acta Derm Venereol; 2009; 89(5):484-7. PubMed ID: 19734973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis.
    Whiley DM; Tickner JA; Kundu RL; Hogan TR; van Hal SJ; Lahra MM
    Lancet Infect Dis; 2023 Aug; 23(8):e268-e269. PubMed ID: 37321241
    [No Abstract]   [Full Text] [Related]  

  • 20. Australian gonococcal surveillance programme, 1 April to 30 June 2014.
    Lahra MM;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E390-2. PubMed ID: 25631604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.